(Q38064950)

28 August 2017

1 reference

title

Convergence of gene and cell therapy (English)

1 reference

28 August 2017

2

Bruce L Levine

1 reference

28 August 2017

Alexey Bersenev

1

1 reference

28 August 2017

publication date

1 November 2012

1 reference

28 August 2017

published in

Regenerative Medicine

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

6 Suppl

1 reference

28 August 2017

page(s)

50-56

1 reference

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

28 August 2017

cites work

1 reference

Hematopoietic stem cell engineering at a crossroads

21 January 2018

1 reference

Ten years of gene therapy for primary immune deficiencies.

21 January 2018

1 reference

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

21 January 2018

1 reference

Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction

21 January 2018

1 reference

Efficacy of gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

Stem-cell gene therapy for the Wiskott-Aldrich syndrome

21 January 2018

1 reference

Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils

21 January 2018

1 reference

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

State-of-the-art gene-based therapies: the road ahead

21 January 2018

1 reference

Gene therapy for primary immunodeficiency

21 January 2018

1 reference

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

21 January 2018

1 reference

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

The promise and potential pitfalls of chimeric antigen receptors

21 January 2018

1 reference

CARs on track in the clinic

21 January 2018

1 reference

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells

21 January 2018

1 reference

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

21 January 2018

1 reference

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

21 January 2018

1 reference

Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial

21 January 2018

1 reference

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

Genetic therapies against HIV.

21 January 2018

1 reference

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

21 January 2018

1 reference

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

21 January 2018

1 reference

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

21 January 2018

1 reference

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

21 January 2018

1 reference

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

21 January 2018

1 reference

Inducible apoptosis as a safety switch for adoptive cell therapy

21 January 2018

1 reference

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

21 January 2018

1 reference

hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence

21 January 2018

1 reference

Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases

21 January 2018

1 reference

21 January 2018

Engineered cell homing

1 reference

21 January 2018

Identifiers

DOI

10.2217/RME.12.71

1 reference

28 August 2017

1 reference